BEACONPHAR

Beacon Pharmaceuticals PLC · Pharmaceuticals and Chemicals · Cat A

56/100

Mixed

৳114.5

DSE Hexagon

Six lenses, each scored 0–100 from the analysis. Integrity is DSE-specific — it reads how organic the price action is (high = clean, low = concentrated-operator risk). Descriptive only, not a recommendation.

Risks & rewards

Risks (0)

No notable risk flags.

Rewards (0)

No notable positives flagged.

Score breakdown

Technical read

RSI (14)69.3

MACDbullish

Bollingerinside bands (+1.9σ)

Price cycle (Wyckoff)MARKUP

Health trendstable

Flow pressureneutral

Valuation

Fair value73.8 (51.7-95.9)

Upside-36.00%

Dividend yield+1.90%

Fundamental verdictSUSTAINABLE

ConfidenceLOW (re-rate ceiling, not target)

Levels

Resistance

৳115

৳121.7

৳126.3

৳131.4

Support

৳113.2

৳105.1

৳100.8

৳97.2

Historical bounce zones

Oct 31, 2024: ৳113.2→৳138 +22%

Dec 12, 2024: ৳116.9→৳142.8 +22%

May 17, 2025: ৳87.4→৳115.6 +32%

Jun 22, 2025: ৳100→৳122 +22%

Aug 12, 2025: ৳105→৳147.5 +40%

Oct 20, 2025: ৳100.5→৳117.2 +17%

Nov 13, 2025: ৳98.9→৳114.2 +15%

Mar 8, 2026: ৳96→৳115 +20%

Historical outlook

Based on how similar setups behaved historically — not a prediction of what will happen.

10-day 40% vs 40% market avg Typical move: -6.3% / -1.3% / 5.6%

30-day 50% vs 42% market avg Typical move: -10.6% / -2.4% / 8.8%

Signals: RSI>70 overbought|Stochastic>80

Reference levels

Descriptive reference points from the analysis — not instructions to buy or sell.

Entry readdip to 105.5–109.9

Reference stopclose<106.6 (buffer)

Reference targetride/trail; ref 143.1

Timing notebuy dips Jun-Aug; trim Sep-Oct; hold+trail

Elevated (score 191) — acceptable only with real earnings and sponsor backing; artificial-activity lens applies. Phase: DORMANT (6% >200-MA, flow neut). ⚠ Balance sheet DETERIORATING (Altman Z falling) — early warning. [fundamentals SUSTAINABLE, payout 51.0%, yield 1.9%]